Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(17 sites)
United States
Neurocrine Clinical Site, Garden Grove, California Neurocrine Clinical Site, La Habra, California Neurocrine Clinical Site, Lemon Grove, California Neurocrine Clinical Site, Oceanside, California Neurocrine Clinical Site, West Hills, California Neurocrine Clinical Site, Hollywood, Florida Neurocrine Clinical Site, Maitland, Florida Neurocrine Clinical Site, Miami, Florida Neurocrine Clinical Site, Tampa, Florida Neurocrine Clinical Site, West Palm Beach, Florida Neurocrine Clinical Site, Atlanta, Georgia Neurocrine Clinical Site, Boston, Massachusetts Neurocrine Clinical Site, Flowood, Mississippi Neurocrine Clinical Site, Cedarhurst, New York Neurocrine Clinical Site, New York, New York Neurocrine Clinical Site, New York, New York Neurocrine Clinical Site, Bellevue, Washington